Target intelligence / Profile preview

Immunoglobulin lambda variable 3-12 (IGLV3-12)

Target
IGLV3-12
Molecular classification
Immunoglobulin variable region gene, Antibody variable domain, Other: Immunoglobulin lambda light chain variable gene
01

Overview

Immunoglobulin lambda variable 3-12 (IGLV3-12) is a human immunoglobulin lambda light chain variable region gene[1][5], found on chromosome 22q11.2[1][5]. Its product constitutes the variable domain of the antibody light chain and serves as one half of the antigen-binding site, paired with a variable heavy chain domain[3][2][6]. This domain is generated through V-J recombination during B lymphocyte development, contributing to the immense diversity of antibodies in the adaptive immune system[2][1]. IGLV3-12 itself is a genomic segment used to form immunoglobulin lambda light chains and does not act as a receptor, therapeutic target, enzyme, or transporter. Dysfunction or abnormal recombination involving immunoglobulin lambda variable region genes, including IGLV3-12, can be associated with lymphoid malignancies such as leukemia or lymphoma[1]. There are no known drugs that directly target IGLV3-12; its role is mainly structural and informational for antibody diversity. Its main biological function pertains to immune recognition and response[2][3][6].

Other names
Immunoglobulin lambda variable 3-12IGLV3-12IGLV312V2-8
02

Biological functions

Immune responseAntigen bindingAntibody diversity generation
03

Disease associations

Cancer (via rearrangements/mutations in lymphoid malignancies[1])Other: Immunodeficiency (via defects in immunoglobulin gene recombination)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-12 (IGLV3-12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-12 (IGLV3-12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call